Abstract
Exsanguination after trauma remains a leading cause of early death in severely injured patients [1]. Sepsis and multiple organ failure are significant causes of mortality in severely injured trauma patients who survive their injury and require a prolonged ICU hospitalization [2]. Despite advances in operative technique and critical care medicine, the treatment options for patients with coagulopathic hemorrhage or severe sepsis have remained relatively unchanged. We report a unique case in which pharmacological modulators of coagulation, recombinant Factor VIIa, and activated protein C were successfully used to treat massive hemorr-hage and then severe sepsis in a severely injured trauma patient.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 399-403 |
| Number of pages | 5 |
| Journal | European Journal of Trauma |
| Volume | 32 |
| Issue number | 4 |
| DOIs | |
| State | Published - Aug 2006 |
Keywords
- Activated protein C
- Hemorrhage
- Recombinant factor VIIa
- Sepsis
- Trauma
ASJC Scopus subject areas
- Surgery
Fingerprint
Dive into the research topics of 'Modulation of the coagulation cascade using recombinant factor VIIa and activated protein C in a severely injured trauma patient'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS